Ear, Nose and Throat Topics Topic page Drugs News Journals Guidelines Clinical Trials Knowledge Centres Drug Data
Content on this page Aspaime gotas Description, Presentation and Dosage Aspaime gotas Precautions, Reactions and Contraindications Related Information
Related News Lymphoseek (Navidea) success in Head and Neck cancer trial Read more FDA approves Karbinal ER (Tris Pharma) for Allergic Rhinitis Read more Dymista(Meda AB) is EU approved via decentralised procedure for Allergic Rhinitis Read more Phase II success for AM 111 (Auris Medical) for acute sensorineural hearing loss Read more Zetonna (Sunovion) launched in US for Allergic Rhinitis Read more Two Phase III studies of OMS ElectroChemotherapy (OncoSec Medical) show QoL benefits Read more FDA approve Dymista (Meda AB) for Seasonal Allergic Rhinitis Read more FDA approves Absolute Pro stent system (Abbott) for PAD Read more Afatinib(Boehringer) enters Phase III trials for Head and Neck Cancer Read more Avastin (Roche/Genentech) prevents spread of Nasopharyngeal Carcinoma in Phase II trial Read more
Recent Updates Drugs Read more ASPAIME 30 GRAGEAS Read more NEO RINACTIVE 100 MCG/PULS AERO 200 DO Read more ALERGIST 60 MG 20 COMPRIMIDOS Read more CONTRANGINA ORRAVAN 2 SUPOSITORIOS 150 MG Read more FLUIDASA 15 MG 10 AMPOLLAS 5 ML View all Clinical Guidelines Read more Surgical management of otitis media with effusion in children Read more BSACI guidelines for the management of allergic and non-allergic rhinitis View all Medical Journals Read more Salvage surgery of vestibular schwannoma after failed radiotherapy: The Gruppo Otologico experience and review of the literature Read more Cognitive behaviour therapy for chronic subjective dizziness: longer-term gains and predictors of disability Read more Design and evaluation of tinnitus synthesis methods: From spectral to spatial matching Read more Contemporary management of pediatric lateral sinus thrombosis: A twenty year review